Bear said  “ This would be a major trial change that would impact the confidentiality of results, integrity of the trial and have huge legal issues with selective disclosure” (My bolding)

Well that would explain the very poor SP performance during this Phase III trial IF this is true. 

IF third eye can get their hands on this info then that means it’s avalable. And IF that is the case then it stands to reason that anyone with some serious cash willing to kick the tires here has access to that info as well, including big Pharma. IF all of this is the case, then what inferences could we draw that big pharma hasn’t opened up their cheque books yet? Hmmmm....

I’m with  Bear.... If this is true then this would be major!

DYODD

Regards 

DND